AIA Group Ltd Has $9.13 Million Stock Position in CVS Health Corporation $CVS

AIA Group Ltd boosted its holdings in CVS Health Corporation (NYSE:CVS) by 389.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 121,145 shares of the pharmacy operator’s stock after purchasing an additional 96,372 shares during the quarter. AIA Group Ltd’s holdings in CVS Health were worth $9,133,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Harbor Capital Advisors Inc. lifted its position in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the period. Caitong International Asset Management Co. Ltd grew its holdings in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Corundum Trust Company INC acquired a new stake in CVS Health in the third quarter worth $29,000. Front Row Advisors LLC increased its stake in CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in shares of CVS Health during the second quarter valued at about $36,000. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Leerink Partners restated an “outperform” rating and issued a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. Sanford C. Bernstein upgraded CVS Health from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $91.00 to $94.00 in a report on Thursday, March 12th. Argus reduced their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. increased their target price on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $95.05.

CVS Health Price Performance

CVS stock opened at $73.03 on Thursday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The business has a 50-day simple moving average of $77.83 and a two-hundred day simple moving average of $77.83. The company has a market capitalization of $92.91 billion, a P/E ratio of 52.92, a price-to-earnings-growth ratio of 0.78 and a beta of 0.49. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.